期刊文献+

甘精胰岛素联合口服降糖药治疗2型糖尿病疗效观察 被引量:13

甘精胰岛素联合口服降糖药治疗2型糖尿病疗效观察
下载PDF
导出
摘要 目的观察甘精胰岛素(来得时)联合口服降糖药治疗2型糖尿病的临床疗效。方法对47例单用口服降糖药效果欠佳的2型糖尿病患者睡前(22时)加用甘精胰岛素分别测定治疗3个月前后的空腹血糖(FPG)、餐后2h血糖(2hPG)、糖化血红蛋白(HbA1c)、空腹C肽、餐后2hC肽,血脂、体重。结果加用甘精胰岛素治疗3个月后,患者的FPG、2hPG、HbA1c较治疗前明显下降(P<0.01),餐后2hC肽较治疗前明显升高,其差异有统计学意义(P<0.01),而对血脂、体重指数影响不大。结论对单用口服药效果不佳的2型糖尿病,加用甘精胰岛素治疗效果显著。 Objective The observation of the effect of the insulin glargine(Lantus)combined with oral hypoglycemic agents in the clinical treatment of type 2 diabetes patients.Methods 47 patients with oral hypoglycemic agents alone is ineffective in type 2 diabetes.Patients bedtime(22 pm)plus insulin glargine treatment were measured before and after 3 months fasting plasma glucose(FPG).Postprandial 2 h blood glucose(2 hPG),glycosylated hemoglobin(HbA1c),fasting C peptide,2-hour postprandial C peptides,lipids,body weight.Results The addition of insulin glargine after 3 months of treatment,the patient's FPG,2 hPG,HbA1c decreased significantly than that before treatment(P0.01),2-hour postprandial C peptide was significantly higher than that before treatment,the difference was significant(P0.01),while the fat,body mass index had little effect.Conclusion The effect of poor oral medication alone in type 2 diabetes,insulin glargine plus a significant treatment effect.
出处 《中国实用医药》 2011年第21期63-64,共2页 China Practical Medicine
关键词 甘精胰岛素 口服降糖药 2型糖尿病 Insulin glargine Oral hypoglycemic agents Type 2 diabetes
  • 相关文献

参考文献3

二级参考文献3

  • 1Gillics Ps, Figgitt Dp, Lamb HM. Insulin glargine[J]. Drugs 2000;59(2) :253 - 260.
  • 2Owens DR. Zinman B, Bolli GB. Insulins today and beyond[J]. Lancet 2001 ;358(9283) :739-746.
  • 3Lindscy Rcihhart, Chad A, Panning, Insulin glarginc: A new bngacting insulin product[ J ]. Am J Hcalth- Stst Pham 2002 ; 59 : 643 - 649.

共引文献15

同被引文献60

  • 1卜石,邢小燕,王娜,赵文惠,杨文英.长效胰岛素联合口服降糖药治疗2型糖尿病的疗效与安全性[J].中国循证医学杂志,2004,4(7):464-467. 被引量:157
  • 2邓海鸥,林凯,李东风,黎映兰,许翎.甘精胰岛素联合口服降糖药治疗老年2型糖尿病的疗效比较[J].广东医学,2006,27(10):1559-1560. 被引量:14
  • 3张晓凡,任素红.格列美脲联合甘精胰岛素治疗2型糖尿病的疗效观察[J].中国误诊学杂志,2007,7(4):747-748. 被引量:8
  • 4中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010版)[M].北京:北京大学医学出版社,2011:1-4.
  • 5Yang WY,Lu JM,Weng JP,et al.Prevalence of diabetes among men and women in China[J].N Engl Med,2010 ;362(12):1090-101.
  • 6International diabetes Federation.Diabetes Atlas (Third Edition)[R].2007.
  • 7Yang YH,Pang SM,Chan MF,et al.Health literacy complication awarness,and diabetic control in patients with type 2 diabetes metllius[J].J Adv Nurs,2008 ;62(1):74-83.
  • 8Ali TK,El Remessy AB.Diabetic retinopathy:current management and experimental therapeutic targets[J].Pharamacotherpy,2009 ; 29 (2):182-92.
  • 9Stratton IM,Adler AI,Neil HAW, et al.Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes:prospective observational study (UKPDS35)[J].BMJ,2000, 321(12):405-412.
  • 10Klein R,Klein BE.Moss SE1Relation of glycemic control to diabetic microvascular complications in diabetes mellitus[J].Ann Intern Med, 1996,124(1 Pt2):90-96.

引证文献13

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部